No abstract listed.
Influence of HLA matching and blood-transfusion on outcome of 502 London Transplant Group renal-graft recipients
Urinary excretion of fibrinogen-related materials, complement, and immunoglobulins in proliferative glomerulonephritis and after renal transplantation
A technique for detecting rejection episodes in human transplant recipients using radioactive fibrinogen
In vitro rosette inhibition by antihuman antilymphocyte serum. Correlation with skin graft prolongation in subhuman primates
Ten-year results of renal transplantation with azathioprine and prednisolone as only immunosuppression
Time of day of taking immunosuppressive agents after renal transplantation: a possible influence on graft survival
High versus "low" dose corticosteroids in recipients of cadaveric kidneys: prospective controlled trial
Towards the Belfast immunosuppressive regimen: a prospective trial of low versus high dose steroids and once versus twice daily immunosuppression
Allogenic & Autologous Therapies
Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.